药品注册申请号:050755
申请类型:NDA (新药申请)
申请人:US ANTIBIOTICS
申请人全名:US ANTIBIOTICS LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 AUGMENTIN ES-600 AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION;ORAL 600MG/5ML;EQ 42.9MG BASE/5ML Yes No AB 2001/06/22 2001/06/22 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/05/01 SUPPL-29(补充) Approval Labeling STANDARD
2022/09/22 SUPPL-25(补充) Approval Labeling STANDARD
2022/06/30 SUPPL-24(补充) Approval Labeling STANDARD
2015/03/16 SUPPL-22(补充) Approval Labeling STANDARD Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.
2014/09/30 SUPPL-21(补充) Approval Manufacturing (CMC) STANDARD
2014/04/08 SUPPL-20(补充) Approval Manufacturing (CMC) STANDARD
2011/08/26 SUPPL-18(补充) Approval Labeling STANDARD
2011/08/26 SUPPL-16(补充) Approval Labeling STANDARD
2009/01/16 SUPPL-14(补充) Approval Labeling STANDARD
2008/04/17 SUPPL-15(补充) Approval Labeling STANDARD
2004/12/17 SUPPL-12(补充) Approval Efficacy UNKNOWN
2004/11/10 SUPPL-11(补充) Approval Labeling STANDARD
2004/06/03 SUPPL-10(补充) Approval Labeling STANDARD
2003/05/12 SUPPL-3(补充) Approval Labeling STANDARD
2002/12/04 SUPPL-4(补充) Approval Manufacturing (CMC) STANDARD
2002/11/27 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
2002/10/17 SUPPL-5(补充) Approval Manufacturing (CMC) STANDARD
2001/06/22 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:AMOXICILLIN; CLAVULANATE POTASSIUM 剂型/给药途径:FOR SUSPENSION;ORAL 规格:600MG/5ML;EQ 42.9MG BASE/5ML 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
050755 001 NDA AUGMENTIN ES-600 AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION;ORAL 600MG/5ML;EQ 42.9MG BASE/5ML Prescription Yes No AB 2001/06/22 US ANTIBIOTICS
065162 001 ANDA AMOXICILLIN AND CLAVULANATE POTASSIUM AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION;ORAL 600MG/5ML;EQ 42.9MG BASE/5ML Prescription No Yes AB 2004/03/12 TEVA
065358 001 ANDA AMOXICILLIN AND CLAVULANATE POTASSIUM AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION;ORAL 600MG/5ML;EQ 42.9MG BASE/5ML Prescription No No AB 2007/08/13 SANDOZ INC
065373 001 ANDA AMOXICILLIN AND CLAVULANATE POTASSIUM AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION;ORAL 600MG/5ML;EQ 42.9MG BASE/5ML Prescription No No AB 2007/11/09 HIKMA PHARMS
201091 001 ANDA AMOXICILLIN AND CLAVULANATE POTASSIUM AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION;ORAL 600MG/5ML;EQ 42.9MG BASE/5ML Prescription No No AB 2011/12/20 AUROBINDO PHARMA LTD
065420 001 ANDA AMOXICILLIN AND CLAVULANATE POTASSIUM AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION;ORAL 600MG/5ML;EQ 42.9MG BASE/5ML Prescription No No AB 2013/12/02 CIPLA
209351 001 ANDA AMOXICILLIN AND CLAVULANATE POTASSIUM AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION;ORAL 600MG/5ML;EQ 42.9MG BASE/5ML Prescription No No AB 2023/09/13 DEVA HOLDING AS
217805 001 ANDA AMOXICILLIN AND CLAVULANATE POTASSIUM AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION;ORAL 600MG/5ML;EQ 42.9MG BASE/5ML Prescription No No AB 2023/12/08 MICRO LABS
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database